FDA Inspection 1208903 — 3D SYSTEMS - LAYERWISE

3D SYSTEMS - LAYERWISE — FEI 3010705004

The FDA completed an inspection of 3D SYSTEMS - LAYERWISE on Jun 15, 2023 in Leuven. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 15, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Compliance: Devices
Location
Leuven (Belgium)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
328621 CFR 820.90(b)(1)Procedures for product review,disposition lack of/inadequate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.